by University of California – San Diego A colorized scanning electron micrograph depicts human red blood cells. Credit: UC San Diego Health Sciences Researchers at University of California San Diego School of Medicine, Sanford Stem Cell Institute and Moores Cancer Center report that a late-stage, pre-clinical small molecule inhibitor, called rebecsinib, reverses malignant hyper-editing by an...
